130 related articles for article (PubMed ID: 17634043)
21. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
22. Removal of dissolved estrogen in sewage effluents by β-cyclodextrin polymer.
Oishi K; Moriuchi A
Sci Total Environ; 2010 Dec; 409(1):112-5. PubMed ID: 20980045
[TBL] [Abstract][Full Text] [Related]
23. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
Zingone G; Rubessa F
Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
[TBL] [Abstract][Full Text] [Related]
24. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
Jarho P; Vander Velde D; Stella VJ
J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
[TBL] [Abstract][Full Text] [Related]
25. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
26. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent.
Rao VM; Zannou EA; Stella VJ
J Pharm Sci; 2011 Apr; 100(4):1576-87. PubMed ID: 24081477
[TBL] [Abstract][Full Text] [Related]
27. Triclosan loaded electrospun nanofibers based on a cyclodextrin polymer and chitosan polyelectrolyte complex.
Ouerghemmi S; Degoutin S; Tabary N; Cazaux F; Maton M; Gaucher V; Janus L; Neut C; Chai F; Blanchemain N; Martel B
Int J Pharm; 2016 Nov; 513(1-2):483-495. PubMed ID: 27664300
[TBL] [Abstract][Full Text] [Related]
28. Efficient Grafting of Cyclodextrin to Alginate and Performance of the Hydrogel for Release of Model Drug.
Omtvedt LA; Dalheim MØ; Nielsen TT; Larsen KL; Strand BL; Aachmann FL
Sci Rep; 2019 Jun; 9(1):9325. PubMed ID: 31249333
[TBL] [Abstract][Full Text] [Related]
29. Surface modification of electrospun polyester nanofibers with cyclodextrin polymer for the removal of phenanthrene from aqueous solution.
Kayaci F; Aytac Z; Uyar T
J Hazard Mater; 2013 Oct; 261():286-94. PubMed ID: 23959248
[TBL] [Abstract][Full Text] [Related]
30. Β-cyclodextrin polymer as a linker to fabricate ternary nanocomposites AuNPs/pATP-β-CDP/rGO and their electrochemical application.
Chen M; Shen X; Liu P; Wei Y; Meng Y; Zheng G; Diao G
Carbohydr Polym; 2015 Mar; 119():26-34. PubMed ID: 25563941
[TBL] [Abstract][Full Text] [Related]
31. Facile synthesis of magnetic-/pH-responsive hydrogel beads based on Fe3O4 nanoparticles and chitosan hydrogel as MTX carriers for controlled drug release.
Wu J; Jiang W; Tian R; Shen Y; Jiang W
J Biomater Sci Polym Ed; 2016 Oct; 27(15):1553-68. PubMed ID: 27464586
[TBL] [Abstract][Full Text] [Related]
32. Cyclodextrin-centred star polymers synthesized via a combination of thiol-ene click and ring opening polymerization.
Zhang Q; Li GZ; Becer CR; Haddleton DM
Chem Commun (Camb); 2012 Aug; 48(65):8063-5. PubMed ID: 22767077
[TBL] [Abstract][Full Text] [Related]
33. Mechanism study on pH-responsive cyclodextrin capped mesoporous silica: effect of different stalk densities and the type of cyclodextrin.
Bai L; Zhao Q; Wang J; Gao Y; Sha Z; Di D; Han N; Wang Y; Zhang J; Wang S
Nanotechnology; 2015 Apr; 26(16):165704. PubMed ID: 25827241
[TBL] [Abstract][Full Text] [Related]
34. Polymeric hollow spheres assembled from ALG-g-PNIPAM and β-cyclodextrin for controlled drug release.
Li G; Yu N; Gao Y; Tao Q; Liu X
Int J Biol Macromol; 2016 Jan; 82():381-6. PubMed ID: 26562555
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of a pH-responsive Mimosa pudica seed mucilage/β- cyclodextrin-co-poly(methacrylate) hydrogel for controlled drug delivery: In vitro and in vivo assessment.
Yasmin T; Mahmood A; Farooq M; Sarfraz RM; Boublia A; Rehman U; Ashraf MU; Bhutto JK; Ernst B; Albrahim M; Elboughdiri N; Yadav KK; Alreshidi MA; Ijaz H; Benguerba Y
Int J Biol Macromol; 2024 May; 268(Pt 2):131832. PubMed ID: 38663704
[TBL] [Abstract][Full Text] [Related]
36. Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability.
Liu Y; Chen GS; Chen Y; Lin J
Bioorg Med Chem; 2005 Jun; 13(12):4037-42. PubMed ID: 15911316
[TBL] [Abstract][Full Text] [Related]
37. Cyclodextrin pendant polymer as an efficient drug carrier for scutellarin.
Liao R; Liu Y; Lv P; Wu D; Xu M; Zheng X
Drug Deliv; 2020 Nov; 27(1):1741-1749. PubMed ID: 33307844
[TBL] [Abstract][Full Text] [Related]
38. Cyclodextrin-mesoporous silica particle composites for controlled antibiotic release. A proof of concept toward colon targeting.
Stjern L; Voittonen S; Weldemichel R; Thuresson S; Agnes M; Benkovics G; Fenyvesi É; Malanga M; Yannakopoulou K; Feiler A; Valetti S
Int J Pharm; 2017 Oct; 531(2):595-605. PubMed ID: 28554545
[TBL] [Abstract][Full Text] [Related]
39. Supramolecular hydrogels from in situ host-guest inclusion between chemically modified cellulose nanocrystals and cyclodextrin.
Lin N; Dufresne A
Biomacromolecules; 2013 Mar; 14(3):871-80. PubMed ID: 23347071
[TBL] [Abstract][Full Text] [Related]
40. Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension.
Pagar KP; Vavia PR
Acta Pharm; 2012 Nov; 62(3):395-410. PubMed ID: 23470351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]